Today, Nov. 16, is the last day for eligible CVS customers to file a claim in a $20.5 million class-action settlement over allegations the company shared customers’ personal and health data with advertisers without consent.
The lawsuit, Brewer v. CVS Pharmacy, Inc. and Criteo Corp., is pending in Broward County Circuit Court in Florida. It alleges that web tracking tools on CVS’s website and mobile app shared users’ personal and health information with advertising firm Criteo without their knowledge. The suit raised claims of negligence, invasion of privacy, and violations of privacy law. Both CVS and Criteo deny any wrongdoing.
CVS spokesperson Amy Thibault said in a statement: “We stand by our privacy practices and believe they comply with applicable laws. The settlement resolves claims based on legal theories that challenge common online industry practices.”
Under the settlement, CVS Health will pay $18.5 million and Criteo will pay $2 million, for a combined fund of $20.5 million.
Who Qualifies
US residents who used CVS.com, CVShealth.com, or the CVS mobile app before July 27 may be eligible. Claim forms must be submitted online or postmarked by today, Nov. 16.
- File online at the official settlement website.
- Download and mail a paper claim form to: CVS Digital Privacy Settlement, c/o Settlement Administrator, P.O. Box 1110, Costa Mesa, CA 92628.
- Questions can be directed to (888) 654-1271 or info@CVSDigitalPrivacySettlement.com.
Payouts are expected to run between $5 and $10 per person. Claims filed without proof of use can receive up to $5; those with valid proof can receive up to $10.
Anyone who wanted to preserve the right to sue CVS independently had to submit an exclusion request by Nov. 1, 2026. The court has not yet given final approval to the settlement, with a hearing scheduled for Dec. 1. If approved, payments would go out 120 days later, via PayPal, Venmo, Zelle, or paper check. Checks will expire 180 days after issue.
A Separate, Larger Case
The privacy settlement is not CVS’s only major legal exposure. The company has separately agreed to pay $315 million to resolve allegations that it illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act between Oct. 17, 2013, and Dec. 2, 2025.
That case alleges CVS billed Medicare and other federal health programs for the illegal prescriptions, in violation of the False Claims Act. It stems from an allegation filed Dec. 13, 2024, in the U.S. District Court for the District of Rhode Island.


Add comment